C

Cannassure Therapeutics Ltd
TASE:CSURE

Watchlist Manager
Cannassure Therapeutics Ltd
TASE:CSURE
Watchlist
Price: 1 900 ILS 1.06%
Updated: May 20, 2024
Section:
 

Wall Street
Price Targets

CSURE Price Targets Summary
Cannassure Therapeutics Ltd

There are no price targets for CSURE.
CSURE Lowest Forecast
Wall Street Target
Not Available
CSURE Average Forecast
Wall Street Target
Not Available
CSURE Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Cannassure Therapeutics Ltd Competitors:
Price Targets
ALK B
ALK-Abello A/S
2% Upside
JNJ
Johnson & Johnson
16% Upside
000020
Dongwha Pharm Co Ltd
66% Upside
AZN
AstraZeneca PLC
8% Upside
ALK B
ALK-Abello A/S
2% Upside
JNJ
Johnson & Johnson
16% Upside
000020
Dongwha Pharm Co Ltd
66% Upside
AZN
AstraZeneca PLC
8% Upside
4746
Formosa Laboratories Inc
48% Upside
V
VRNO
Verano Holdings Corp
149% Upside
DMP
Dermapharm Holding SE
47% Upside
H
106190
High Tech Pharm Co Ltd
91% Upside

Revenue
Forecast

Revenue Estimate
Cannassure Therapeutics Ltd

Revenue forecast
is not available for
Cannassure Therapeutics Ltd

Operating Income
Forecast

Operating Income Estimate
Cannassure Therapeutics Ltd

Operating Income forecast
is not available for
Cannassure Therapeutics Ltd

Net Income
Forecast

Net Income Estimate
Cannassure Therapeutics Ltd

Net Income forecast
is not available for
Cannassure Therapeutics Ltd

See Also

Summary
CSURE intrinsic value, competitors valuation, and company profile.
DCF Valuation
CSURE stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CSURE stock valuation using valuation multiples.
Wall Street Estimates
CSURE price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CSURE stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CSURE's stock price target?
Not Available

CSURE doesn't have any price targets made by Wall Street professionals.

ALPHA SPREAD
Join more than 138,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.